| Sal-liz | |
| 1000 Lakeland Square Ext, Ste 500, Flowood, Mississippi 39232 | |
| (601) 932-0179 |
| Name | Sal-liz |
|---|---|
| Organization Name | Sal-liz Inc |
| Location | 1000 Lakeland Square Ext, Ste 500, Flowood, Mississippi 39232 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (601) 932-0179 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
No drug treatment exists for hydrocephalus, the buildup of fluid known as "water on the brain" that can occur at any age.
W. L. Gore & Associates (Gore) has received CE Mark for the GORE Hybrid Vascular Graft. The graft is designed to expand treatment options for optimal outflow by maximizing the number of access sites available.
Inhibiting the transfer of calcium ions into the cell's powerhouse is specifically toxic to cancer cells, according to an article published this week in Cell Reports by researchers from the Perelman School of Medicine at the University of Pennsylvania.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
RainDance Technologies, Inc., the Digital Biology Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well as stratified cancer medicine and basic research.
› Verified 4 days ago
| NPI Number | 1770655136 |
| Organization Name | SAL-LIZ INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1000 Lakeland Square, Flowood, MS 39232 |
| Phone Number | 601-932-0179 |
News Archive
No drug treatment exists for hydrocephalus, the buildup of fluid known as "water on the brain" that can occur at any age.
W. L. Gore & Associates (Gore) has received CE Mark for the GORE Hybrid Vascular Graft. The graft is designed to expand treatment options for optimal outflow by maximizing the number of access sites available.
Inhibiting the transfer of calcium ions into the cell's powerhouse is specifically toxic to cancer cells, according to an article published this week in Cell Reports by researchers from the Perelman School of Medicine at the University of Pennsylvania.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
RainDance Technologies, Inc., the Digital Biology Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well as stratified cancer medicine and basic research.
› Verified 4 days ago
News Archive
No drug treatment exists for hydrocephalus, the buildup of fluid known as "water on the brain" that can occur at any age.
W. L. Gore & Associates (Gore) has received CE Mark for the GORE Hybrid Vascular Graft. The graft is designed to expand treatment options for optimal outflow by maximizing the number of access sites available.
Inhibiting the transfer of calcium ions into the cell's powerhouse is specifically toxic to cancer cells, according to an article published this week in Cell Reports by researchers from the Perelman School of Medicine at the University of Pennsylvania.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
RainDance Technologies, Inc., the Digital Biology Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well as stratified cancer medicine and basic research.
› Verified 4 days ago
Mobility Medical, Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 554 Park Lane, Flowood, Mississippi 39232 Phone: (601) 932-1001 | |
Amber Specialty Pharmacy Type: Medicare Supplier Location: 3010 Lakeland Cv, Flowood, Mississippi 39232 Phone: (888) 370-1724 | |
Cvs Pharmacy #08311 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4899 Lakeland Dr, Flowood, Mississippi 39232 Phone: (601) 919-3044 | |
Cvs Pharmacy #17038 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 170 Promenade Blvd, Flowood, Mississippi 39232 Phone: (601) 992-0676 | |
Walmart Pharmacy 10-2755 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5341 Lakeland Dr, Flowood, Mississippi 39232 Phone: (601) 992-8144 |